FDA Inspection 1172544 — Sanford Reproductive Medicine
The FDA completed an inspection of Sanford Reproductive Medicine on May 31, 2022 in Fargo, ND. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 31, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Fargo, ND (United States)